These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 12126344)

  • 1. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
    Mohan V; Deepa R; Velmurugan K; Premalatha G
    Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.
    Vukovich T; Proidl S; Knöbl P; Teufelsbauer H; Schnack C; Schernthaner G
    Thromb Haemost; 1992 Sep; 68(3):253-6. PubMed ID: 1440487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
    Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
    Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D; Eriksson JW; Boman K; Svensson MK
    Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased sP-selectin and other cardiovascular risk factors: fibrinogen, tissue plasminogen activator (t-PA Ag) and acute phase proteins after kidney transplantation].
    Kvasnicka J; Viklický O; Umlaufová A; Kvasnicka T; Teplá E; Homolková H; Malíkova I; Sauerová R
    Sb Lek; 2002; 103(3):411-7. PubMed ID: 12688185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease.
    Carter AM; Catto AJ; Grant PJ
    Thromb Haemost; 1998 Oct; 80(4):632-6. PubMed ID: 9798983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes.
    Pratte KA; Barón AE; Ogden LG; Hassell KL; Rewers M; Hokanson JE
    J Diabetes Complications; 2009; 23(6):387-93. PubMed ID: 18768333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
    Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK
    Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
    Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR
    Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
    Lundblad D; Dinesen B; Rautio A; Røder ME; Eliasson M
    J Intern Med; 2005 Jul; 258(1):13-20. PubMed ID: 15953128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.
    Achari V; Thakur AK
    J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.